| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |